BRPI9908132C1 - composição farmacêutica líquida para administração oral - Google Patents
composição farmacêutica líquida para administração oralInfo
- Publication number
- BRPI9908132C1 BRPI9908132C1 BRPI9908132A BRPI9908132A BRPI9908132C1 BR PI9908132 C1 BRPI9908132 C1 BR PI9908132C1 BR PI9908132 A BRPI9908132 A BR PI9908132A BR PI9908132 A BRPI9908132 A BR PI9908132A BR PI9908132 C1 BRPI9908132 C1 BR PI9908132C1
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- liquid pharmaceutical
- oral administration
- agents
- benzoxazinone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
<b>"composição farmacêutica líquida para administração oral"<d> a presente invenção trata de uma composição farmacêutica líquida oral palatável de compostos de benzoxazinona utilizáveis como inibidores da transcriptase reversa de hiv, a qual compreende o ingrediente ativo de benzoxazinona em um veículo líquido que compreende triglicerídios de ácidos graxos de cadeias médias. outros agentes de formulação, tais como agentes adoçantes, agentes de suspensão de lecitina, etc., podem ser opcionalmente adicionados.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7488198P | 1998-02-17 | 1998-02-17 | |
PCT/US1999/003318 WO1999040921A2 (en) | 1998-02-17 | 1999-02-17 | Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI9908132C1 true BRPI9908132C1 (pt) | 2021-05-25 |
Family
ID=22122226
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI9908132A BRPI9908132B8 (pt) | 1998-02-17 | 1999-02-17 | composição farmacêutica líquida para administração oral |
BRPI9908132A BRPI9908132C1 (pt) | 1998-02-17 | 1999-02-17 | composição farmacêutica líquida para administração oral |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI9908132A BRPI9908132B8 (pt) | 1998-02-17 | 1999-02-17 | composição farmacêutica líquida para administração oral |
Country Status (19)
Country | Link |
---|---|
US (1) | US6235733B1 (pt) |
EP (1) | EP1054674B1 (pt) |
JP (1) | JP2002502878A (pt) |
CN (1) | CN1170541C (pt) |
AR (1) | AR018092A1 (pt) |
AT (1) | ATE345802T1 (pt) |
AU (1) | AU745008C (pt) |
BR (2) | BRPI9908132B8 (pt) |
CA (1) | CA2319609C (pt) |
DE (1) | DE69934097T2 (pt) |
ES (1) | ES2277429T3 (pt) |
HK (1) | HK1030749A1 (pt) |
HR (1) | HRP990049A2 (pt) |
IL (1) | IL137763A0 (pt) |
MY (1) | MY139034A (pt) |
NZ (1) | NZ506579A (pt) |
TW (1) | TW528596B (pt) |
WO (1) | WO1999040921A2 (pt) |
ZA (1) | ZA99981B (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019530727A (ja) * | 2016-10-11 | 2019-10-24 | オクタ ファーマシューティカルズ | ラモトリギンを含む経口懸濁液用の粉末 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0484281B2 (en) * | 1990-11-02 | 2000-11-22 | Novartis AG | Cyclosporins |
US5494936A (en) * | 1992-04-27 | 1996-02-27 | Vyrex Corporation | Delivery formulation for probucol |
US5519021A (en) | 1992-08-07 | 1996-05-21 | Merck & Co., Inc. | Benzoxazinones as inhibitors of HIV reverse transcriptase |
AU1694295A (en) | 1994-01-28 | 1995-08-15 | Merck & Co., Inc. | Benzoxazinones as inhibitors of hiv reverse transcriptase |
AU712120B2 (en) | 1996-05-02 | 1999-10-28 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
AU4802797A (en) * | 1996-10-02 | 1998-04-24 | Du Pont Pharmaceuticals Company | 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv rever se transcriptase inhibitors and intermediates and processes for making the same |
-
1999
- 1999-02-08 ZA ZA9900981A patent/ZA99981B/xx unknown
- 1999-02-13 MY MYPI99000529A patent/MY139034A/en unknown
- 1999-02-16 AR ARP990100630A patent/AR018092A1/es active IP Right Grant
- 1999-02-16 US US09/250,508 patent/US6235733B1/en not_active Expired - Lifetime
- 1999-02-17 EP EP99907077A patent/EP1054674B1/en not_active Expired - Lifetime
- 1999-02-17 CN CNB998029505A patent/CN1170541C/zh not_active Expired - Lifetime
- 1999-02-17 AT AT99907077T patent/ATE345802T1/de active
- 1999-02-17 JP JP2000531173A patent/JP2002502878A/ja active Pending
- 1999-02-17 NZ NZ506579A patent/NZ506579A/xx not_active IP Right Cessation
- 1999-02-17 WO PCT/US1999/003318 patent/WO1999040921A2/en active IP Right Grant
- 1999-02-17 CA CA002319609A patent/CA2319609C/en not_active Expired - Lifetime
- 1999-02-17 ES ES99907077T patent/ES2277429T3/es not_active Expired - Lifetime
- 1999-02-17 HR HR60/074,881A patent/HRP990049A2/hr not_active Application Discontinuation
- 1999-02-17 IL IL13776399A patent/IL137763A0/xx not_active IP Right Cessation
- 1999-02-17 DE DE69934097T patent/DE69934097T2/de not_active Expired - Lifetime
- 1999-02-17 BR BRPI9908132A patent/BRPI9908132B8/pt not_active IP Right Cessation
- 1999-02-17 BR BRPI9908132A patent/BRPI9908132C1/pt unknown
- 1999-02-17 AU AU26827/99A patent/AU745008C/en not_active Expired
- 1999-02-23 TW TW088102274A patent/TW528596B/zh not_active IP Right Cessation
-
2001
- 2001-03-08 HK HK01101680A patent/HK1030749A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BRPI9908132B8 (pt) | 2016-11-16 |
WO1999040921A3 (en) | 1999-11-04 |
HK1030749A1 (en) | 2001-05-18 |
MY139034A (en) | 2009-08-28 |
ZA99981B (en) | 2000-08-08 |
CN1291098A (zh) | 2001-04-11 |
HRP990049A2 (en) | 1999-12-31 |
AU745008B2 (en) | 2002-03-07 |
CN1170541C (zh) | 2004-10-13 |
AR018092A1 (es) | 2001-10-31 |
EP1054674B1 (en) | 2006-11-22 |
TW528596B (en) | 2003-04-21 |
BR9908132A (pt) | 2000-12-05 |
DE69934097D1 (de) | 2007-01-04 |
ES2277429T3 (es) | 2007-07-01 |
EP1054674A2 (en) | 2000-11-29 |
NZ506579A (en) | 2002-11-26 |
US6235733B1 (en) | 2001-05-22 |
DE69934097T2 (de) | 2007-06-28 |
IL137763A0 (en) | 2001-10-31 |
AU745008C (en) | 2003-03-27 |
WO1999040921A2 (en) | 1999-08-19 |
CA2319609A1 (en) | 1999-08-19 |
BRPI9908132B1 (pt) | 2015-07-14 |
CA2319609C (en) | 2007-09-18 |
ATE345802T1 (de) | 2006-12-15 |
JP2002502878A (ja) | 2002-01-29 |
AU2682799A (en) | 1999-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2192234T3 (es) | Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos. | |
PA8548001A1 (es) | Derivados aromaticos de acidos dicarboxilicos | |
HRP20010615B1 (en) | Pharmaceutical compositions containing proton pump inhibitors | |
AR023228A1 (es) | Composiciones en espuma estables | |
ES2075202T3 (es) | Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen. | |
AR025959A1 (es) | DERIVADOS DE TER.-BUTIL-(7-METIL-IMIDAZO[1,2,a]PIRIDIN-3-IL)-AMINA, PROCEDIMIENTO PARA SU PREPARACION, MEDICAMENTOS QUE LOS CONTIENEN, SU USO PARA LAPREPARACION DE UN MEDICAMENTO PARA LA INHIBICION DE NO-SINTASA Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN | |
BR9907647A (pt) | Composições contendo composto orgânicos | |
CA2207835A1 (fr) | Nouveaux derives du 3-(piperid-4-yl) 1,2-benzisoxazole et du 3-(piperazin-4-yl) 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent | |
ATE270544T1 (de) | Halbfeste arzneizubereitung enthaltend isotretinoin | |
BR0014818A (pt) | Imidazo-3-il-aminas bicìclicas procedimento de preparação e medicamentos que contém como substância ativa pelo menos uma imidazo-3-il-amina bicìclica | |
BR9714310A (pt) | Composição farmacêutica | |
BRPI0513673A (pt) | método para aumentar a eficácia e o transporte dos compostos biologicamente ativos enteralmente administrados, veìculo utilizado na administração enteral de compostos biologicamente ativos, composição farmacêutica e uso de uma quantidade eficaz de um ou mais derivados de fosfato | |
BR0007294A (pt) | Formulações farmacêuticas aperfeiçoadas | |
ES2151698T3 (es) | Nuevos derivados de 6-hidroxi y 6-oxo-androstan activos sobre el sistema cardiovascular y composiciones farmaceuticas que los contienen. | |
ES2044561T3 (es) | Composiciones liquidas administrables por via oral a base de aceites comestibles. | |
BRPI9908132C1 (pt) | composição farmacêutica líquida para administração oral | |
BRPI9916820B8 (pt) | composição compreendendo 9[2[[bis[(pivaloilóxi)metil]fosfono]metóxi]etil]adenina, comprimido ou cápsula e método | |
DE69813263D1 (de) | Hydrazono-benzazulen-derivate, pharmazeutische zusammensetzungen und zwischenprodukte | |
ES2159843T3 (es) | Derivados de 5,11-dihidrodibenzo(b,e)(1,4)oxazepina y composiciones medicamentosas que los contienen. | |
BR9707770C1 (pt) | Tifluzamida com eficácia aperfeiçoada | |
AR012972A1 (es) | Forma farmaceutica para la administracion de paclitaxel, proceso para la preparacion de una composicion de paclitaxel lista para usar y uso de estacomposicion | |
DE69809435D1 (de) | Inhibitor- und konservierungsmittelzusammensetzung | |
MX9207543A (es) | Sales estables de acido (+)-(1s,2r)-[[b.(2-hidroxilamino-2-oxoetil)-n-metilamino]carbonil]cicl ohexan-1-carboxilico, procedimiento para su preparacion, y composiciones farmaceuticas que las contienen | |
DK1061938T3 (da) | Orale sammensætninger med cytotoksiske proteiner i lav dosis | |
ES2179667T3 (es) | Nuevas formulaciones inyectables que contienen ramoplanina. |